1. Fisher DA, Polk DH. Development of the thyroid. Baillieres Clin Endocrinol Metab. 1989;3(3):627-657.
2. van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Semin Neonatol. 2004;9(1):3-11.
3. Williams FL, Visser TJ, Hume R. Transient hypothyroxinaemia in preterm infants. Early Hum Dev. 2006;82(12):797-802.
4. Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed. 2002;87(3):F165-171.
5. Williams F, Hume R. The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Ann Clin Biochem. 2011;48(Pt 1):7-22.
6. Vanhole C, Aerssens P, Naulaers G, et al. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res. 1997;42(1):87-92.
7. Rapaport R. Thyroid function in the very low birth weight newborn: rescreen or reevaluate? J Pediatr. 2002;140(3):287-289.
8. LaFranchi SH. Screening preterm infants for congenital hypothyroidism: better the second time around. J Pediatr. 2014;164(6):1259-1261.
9. Vigone MC, Caiulo S, Di Frenna M, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr. 2014;164(6):1296-1302.
10. Vincent MA, Rodd C, Dussault JH, Van Vliet G. Very low birth weight newborns do not need repeat screening for congenital hypothyroidism. J Pediatr. 2002;140(3):311-314.
11. Woo HC, Lizarda A, Tucker R, et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr. 2011;158(4):538-542.
12. Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr. 2001;139(2):182-188.
13. Gupta V, Lee M. Central hypothyroidism. Indian J Endocrinol Metab. 2011;15(Suppl 2):S99-S106.
14. Hollanders JJ, Israels J, van der Pal SM, et al. No Association Between Transient Hypothyroxinemia of Prematurity and Neurodevelopmental Outcome in Young Adulthood. J Clin Endocrinol Metab. 2015;100(12):4648-4653.
15. Kanike N, Davis A, Shekhawat PS. Transient hypothyroidism in the newborn: to treat or not to treat. Transl Pediatr. 2017;6(4):349-358.
16. Eerdekens A, Langouche L, Van den Berghe G, Verhaeghe J, Naulaers G, Vanhole C. Review shows that thyroid hormone substitution could benefit transient hypothyroxinaemia of prematurity but treatment strategies need to be clarified. Acta Paediatr. 2019;108(5):792-805.
17. van Wassenaer AG, Kok JH, Dekker FW, Endert E, de Vijlder JJ. Thyroxine administration to infants of less than 30 weeks gestational age decreases plasma tri-iodothyronine concentrations. Eur J Endocrinol. 1998;139(5):508-515.
18. van Wassenaer AG, Westera J, Houtzager BA, Kok JH. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial. Pediatrics. 2005;116(5):e613-618.
19. La Gamma EF, van Wassenaer AG, Ares S, et al. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation. Pediatrics. 2009;124(2):e258-268.
20. Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2007(1):CD005948.
21. Uchiyama A, Kushima R, Watanabe T, Kusuda S. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial. J Pediatr Endocrinol Metab. 2015;28(1-2):177-182.
22. van Wassenaer-Leemhuis A, Ares S, Golombek S, et al. Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. Thyroid. 2014;24(7):1162-1169.
23. Yagasaki H, Kobayashi K, Nemoto A, Naito A, Sugita K, Ohyama K. Late-onset circulatory dysfunction after thyroid hormone treatment in an extremely low birth weight infant. J Pediatr Endocrinol Metab. 2010;23(1-2):153-158.
24. Kawai M, Kusuda S, Cho K, et al. Nationwide surveillance of circulatory collapse associated with levothyroxine administration in very-low-birthweight infants in Japan. Pediatr Int. 2012;54(2):177-181.
25. Rapaport R, Sills I, Patel U, et al. Thyrotropin-releasing hormone stimulation tests in infants. J Clin Endocrinol Metab. 1993;77(4):889-894.
26. Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab. 2003;88(12):5696-5703.
27. van Tijn DA, de Vijlder JJ, Vulsma T. Role of the thyrotropin-releasing hormone stimulation test in diagnosis of congenital central hypothyroidism in infants. J Clin Endocrinol Metab. 2008;93(2):410-419.
28. Rapaport R, Akler G, Regelmann MO, Greig F. Time for thyrotropin releasing hormone to return to the United States of America. Thyroid. 2010;20(9):947-948.
29. Niwa F, Kawai M, Kanazawa H, et al. Hyperthyrotropinemia at 2 weeks of age indicates thyroid dysfunction and predicts the occurrence of delayed elevation of thyrotropin in very low birth weight infants. Clin Endocrinol (Oxf). 2012;77(2):255-261.
30. Yamamoto A, Kawai M, Iwanaga K, et al. Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity. J Perinatol. 2015;35(9):725-728.
31. Karna P. Developmental follow-up of very low birthweight premature infants with low free thyroxine. Am J Perinatol. 1991;8(4):288-291.
32. Valerio PG, van Wassenaer AG, de Vijlder JJ, Kok JH. A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatr Res. 2004;55(2):248-253.
33. van Wassenaer AG, Kok JH. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects. Semin Perinatol. 2008;32(6):423-430.
34. Fisher DA, Nelson JC, Carlton EI, Wilcox RB. Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid. 2000;10(3):229-234.
35. DeGroot LJ. The Non-Thyroidal Illness Syndrome. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA)2000.
36. de Vries EM, Fliers E, Boelen A. The molecular basis of the non-thyroidal illness syndrome. J Endocrinol. 2015;225(3):R67-81.